Lung Cancer News

The addition of cemiplimab to chemotherapy significantly improved pain symptoms and delayed time to definitive clinically meaningful deterioration of disease symptoms and functions among patients with advanced non-small cell lung cancer.

Patients with non-small cell lung cancer who had stopped smoking before diagnosis had higher rates of survival after diagnosis, results of a retrospective cohort study showed.

Obesity-related cancer mortality rates tended to be higher in counties with limited access to grocery stores or greater access to fast food, according to data published in JAMA Oncology.

Low-dose olanzapine significantly improved appetite and weight gain among patients with newly diagnosed cancer undergoing chemotherapy, according to study results published in Journal of Clinical Oncology.

More than three-fourths of newspaper articles on lung cancer screening published from 2010 to 2022 had a positive sentiment, according to study results published in American Journal of Roentgenology.

Asthma appeared associated with a 1.36-fold increased risk for developing cancer, according to research conducted at University of Florida.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.

Use of a nurse navigator led to the discovery of more patients eligible for low-dose CT lung cancer screening and more screenings ordered, according to results published in Annals of Family Medicine.

A targeted cancer drug developed by researchers at Norwegian University of Science and Technology and spin-off company APIM Therapeutics has demonstrated positive findings in phase 1 trials, according to a paper published in Oncogene.

Knowledge, expectations and attitudes of patients with cancer about genomic tumor testing appeared to be associated with their respective education and income levels, according to a study published in JCO Precision Oncology.